Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/11/2025

Estrogen Patch Dosage Guidelines

Dosing Guidelines for Adults

  • For adult women with premature ovarian insufficiency or postmenopausal symptoms, the recommended estradiol transdermal patch dosage is 100-200 mcg/day for adults, with lower starting doses of 25-50 mcg/day that can be titrated upward based on symptom control, as recommended by the guideline society, with a strength of evidence based on clinical trials 1, 2
  • For maintenance therapy in adults, the recommended dose range is 100-200 mcg/day of transdermal estradiol, according to the guideline society, with a strength of evidence based on clinical trials 1, 2

Special Considerations for Adolescents with Premature Ovarian Insufficiency

  • For adolescents requiring pubertal induction, a more gradual approach is recommended, starting with 6.25-12.5 mcg/day (1/8 to 1/4 of a patch) and gradually increasing every 6 months over 2-3 years, as recommended by the guideline society, with a strength of evidence based on clinical trials 1, 4, 6
  • The dose should progress through 25, 37.5, 50, 75 mcg/day doses before reaching adult dose, according to the guideline society, with a strength of evidence based on clinical trials 1
  • Progestin should be added after 2-3 years of estrogen therapy or when breakthrough bleeding occurs, as recommended by the guideline society, with a strength of evidence based on clinical trials 1

Dosing Schedule and Administration

  • For women with an intact uterus, progesterone (100-200 mg daily for 12-14 days every 28 days) should be added for endometrial protection, as recommended by the guideline society, with a strength of evidence based on clinical trials 3

Monitoring and Treatment Duration

  • Hormone therapy should be continued until the average age of natural menopause for women with premature ovarian insufficiency, as recommended by the guideline society, with a strength of evidence based on clinical trials 3